$0.76 -0.03 (-3.80%)
11/25/2009 4:00 PM

Antigenics, Inc. (AGEN)

CAPS Rating: 2 out of 5

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

Featured Broker Partners